search
Back to results

BeWell24: Smartphone-based Diabetes Prevention in the VA

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
BeWell24 smartphone app
Health education app
Sponsored by
Arizona State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diabetes Mellitus, Type 2 focused on measuring physical activity, sleep, sedentary behavior, dietary intake, smartphone

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Veterans ages 18 and older
  • Regularly use an appropriate Apple (iOS6 or higher) or Android (2.3 or higher) smartphone or tablet device
  • Risk for "prediabetes" based upon clinician judgment - clinicians may rely on laboratory data review in the prior 12 months including: (a) HbA1c 5.7-6.4%; and (b) glucose, HDL-cholesterol, triglycerides, and weight

Exclusion Criteria:

  • long distance or insufficient transportation to the Veterans hospital to make participation in quarterly visits difficult;
  • severe personal, health, cognitive or psychological conditions that prevent participation or severely limit lifestyle changes
  • limited physical mobility, untreated sleep disorder, or other underlying disorder that requires treatment or would make lifestyle change contraindicated
  • current participation in other diet, weight loss, or lifestyle programs
  • recent or imminent changes in medications that would substantially alter glucose metabolism (e.g., steroids, anti-depressive medications associated with weight gain)
  • recent weight gain or loss of more than 10 kg

Sites / Locations

  • Phoenix VA Healthcare System
  • Arizona State University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

BeWell24 smartphone app

Health education smartphone app

Arm Description

Smartphone app, linked with commercial activity monitor, to support lifestyle changes in physical activity, sleep, sedentary behavior, and dietary intake.

Smartphone app with basic health education content, designed to control for non-specific treatment effects and match for smartphone app novelty.

Outcomes

Primary Outcome Measures

HbA1c
Circulating levels of Hemoglobin A1c
Fasting glucose
Fasting levels of glucose

Secondary Outcome Measures

Sleep duration (minutes/night) measured by wrist actigraphy
Sleep duration (measured by wrist actigraphy)
Sedentary behavior (minutes/day) measured by wrist actigraphy
Measure of sedentary time (measured by wrist actigraphy)
Moderate-vigorous physical activity (minutes/day) measured by wrist actigraphy
Measure of moderate-vigorous physical activity (measured by wrist actigraphy)
Dietary quality measured by the NCI dietary factor screener
Self-reported dietary quality

Full Information

First Posted
June 23, 2017
Last Updated
May 8, 2020
Sponsor
Arizona State University
Collaborators
Phoenix VA Health Care System
search

1. Study Identification

Unique Protocol Identification Number
NCT03202277
Brief Title
BeWell24: Smartphone-based Diabetes Prevention in the VA
Official Title
BeWell24: Smartphone-based Diabetes Prevention in the VA
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
September 17, 2017 (Actual)
Primary Completion Date
December 14, 2019 (Actual)
Study Completion Date
December 14, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Arizona State University
Collaborators
Phoenix VA Health Care System

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Type 2 diabetes (T2D) is a national epidemic and current lifestyle programs and medications are not effectively managing the crisis. This project aims to test a novel smartphone-delivered intervention that simultaneously targets multiple health behaviors (i.e., sleep, sedentary behavior, physical activity,dietary intake) within clinical settings at a large Veteran Health Administration regional hospital. If effective, this project has potential for large-scale implementation nationwide through the VA healthcare system and broad applicability for other populations at T2D risk as well as other disorders.
Detailed Description
Type 2 diabetes (T2D) affects 26 million Americans and "prediabetes" affects 86 million more. If this epidemic is not addressed immediately, 23% of Americans will have T2D by 2030. Current lifestyle programs to prevent diabetes are complex to deliver, costly, and have limited scalability. Medications do not clearly modify the disease process and have a number of side effects. New approaches are needed that can address this epidemic on a population scale. mHealth technologies (e.g., smartphones) are deeply integrated into our lives and can target the daily lifestyle behaviors that underpin the T2D epidemic. The Veterans Health Administration (VHA) is an ideal setting to test mHealth approaches because they are at the forefront of harnessing smartphone technologies to deliver care with the advent of the "VA App Store." As the nation's largest integrated healthcare system, VHA has a central dissemination infrastructure to deliver smartphone interventions to over 5.5 million Veterans. BeWell24, an adaptive and multicomponent smartphone "app" was developed based on the unique needs and desires of US Veterans and VHA clinical teams. BeWell24 targets behaviors across the 24 hours - sleep, sedentary behavior, and more active behaviors - and preliminary data suggest reductions in fasting glucose among prediabetics of 12.3% in just 8 weeks of use. A dietary component will be added to the app to further enhance the potency of the intervention. The objective now is to test whether the delivery and integration of this app into routine clinical care settings can improve glycemic control over 9 months. A randomized controlled trial of 120 prediabetic Veterans is proposed. The first aim is to test whether BeWell24 significantly improves glycemic control (reduce fasting glucose and HbA1c) over 9 months relative to usual care. Objectively-measured changes is targeted behaviors (sleep, sedentary behavior, physical activity, and dietary intake) and other key cardiometabolic biomarkers (weight/body fat, blood pressure, lipids, insulin, and hs-CRP) will also be explored. The second and third aims are to assess factors impacting scalability of BeWell24 from patient and provider perspectives to optimize opportunities for large-scale dissemination if efficacious. Program reach/retention, app usage, treatment acceptability, program costs, and clinical integration factors will be studied. Unique features of this proposal are the rigorous cluster-randomized design; testing in a highly integrated, nationwide, clinical setting; and use of a highly sophisticated smartphone platform uniquely designed for the population and targets multiple health behaviors impacting T2D risk. The long-term goal is to establish an effective diabetes prevention program among Veterans that can be used to complement and enhance existing clinical support. If effective, this approach could be rapidly scaled to Veterans nationwide and could have broad applicability for other populations at disparate T2D risk as well as other disorders.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
physical activity, sleep, sedentary behavior, dietary intake, smartphone

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
BeWell24 smartphone app
Arm Type
Experimental
Arm Description
Smartphone app, linked with commercial activity monitor, to support lifestyle changes in physical activity, sleep, sedentary behavior, and dietary intake.
Arm Title
Health education smartphone app
Arm Type
Active Comparator
Arm Description
Smartphone app with basic health education content, designed to control for non-specific treatment effects and match for smartphone app novelty.
Intervention Type
Behavioral
Intervention Name(s)
BeWell24 smartphone app
Intervention Description
This app delivers an evidence-based suite of lifestyle interventions targeting behavior change in sleep, sedentary behavior, physical activity, and dietary intake. The app connects with a commercially available activity monitor to provide real-time feedback on behaviors over time.
Intervention Type
Behavioral
Intervention Name(s)
Health education app
Intervention Description
This app delivers basic health education and hygiene content related to sleep, sedentary behavior, physical activity, and dietary intake.
Primary Outcome Measure Information:
Title
HbA1c
Description
Circulating levels of Hemoglobin A1c
Time Frame
9 months
Title
Fasting glucose
Description
Fasting levels of glucose
Time Frame
9 months
Secondary Outcome Measure Information:
Title
Sleep duration (minutes/night) measured by wrist actigraphy
Description
Sleep duration (measured by wrist actigraphy)
Time Frame
9 months
Title
Sedentary behavior (minutes/day) measured by wrist actigraphy
Description
Measure of sedentary time (measured by wrist actigraphy)
Time Frame
9 months
Title
Moderate-vigorous physical activity (minutes/day) measured by wrist actigraphy
Description
Measure of moderate-vigorous physical activity (measured by wrist actigraphy)
Time Frame
9 months
Title
Dietary quality measured by the NCI dietary factor screener
Description
Self-reported dietary quality
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Veterans ages 18 and older Regularly use an appropriate Apple (iOS6 or higher) or Android (2.3 or higher) smartphone or tablet device Risk for "prediabetes" based upon clinician judgment - clinicians may rely on laboratory data review in the prior 12 months including: (a) HbA1c 5.7-6.4%; and (b) glucose, HDL-cholesterol, triglycerides, and weight Exclusion Criteria: long distance or insufficient transportation to the Veterans hospital to make participation in quarterly visits difficult; severe personal, health, cognitive or psychological conditions that prevent participation or severely limit lifestyle changes limited physical mobility, untreated sleep disorder, or other underlying disorder that requires treatment or would make lifestyle change contraindicated current participation in other diet, weight loss, or lifestyle programs recent or imminent changes in medications that would substantially alter glucose metabolism (e.g., steroids, anti-depressive medications associated with weight gain) recent weight gain or loss of more than 10 kg
Facility Information:
Facility Name
Phoenix VA Healthcare System
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85012
Country
United States
Facility Name
Arizona State University
City
Tempe
State/Province
Arizona
ZIP/Postal Code
85281
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

BeWell24: Smartphone-based Diabetes Prevention in the VA

We'll reach out to this number within 24 hrs